BioCentury | Dec 15, 2017
Company News

Inscripta offers emerging CRISPR enzyme for free

...provide its CRISPR enzyme MAD7 free of charge to researchers for R&D use. Inscripta (formerly Muse Biotechnology Inc....
BioCentury | Dec 13, 2017
Company News

Inscripta offers emerging CRISPR enzyme for free

...provide its CRISPR enzyme MAD7 free of charge to researchers for R&D use. Inscripta (formerly Muse Biotechnology Inc....
BioCentury | Mar 3, 2017
Financial News

Muse Biotechnology completes venture financing

...On Feb. 28, genome engineering company Muse Biotechnology Inc. (Boulder, Colo.) raised $23 million in a series B...
...by Venrock. Foresite Capital and Paladin Capital participated, as did existing investors NanoDimension and Spruce/MLS. Muse Biotechnology Inc....
BioCentury | Mar 1, 2017
Financial News

Muse raises $23M in series B

...Genome engineering company Muse Biotechnology Inc. (Boulder, Colo.) said it raised $23 million in an oversubscribed series B...
Items per page:
1 - 4 of 4
BioCentury | Dec 15, 2017
Company News

Inscripta offers emerging CRISPR enzyme for free

...provide its CRISPR enzyme MAD7 free of charge to researchers for R&D use. Inscripta (formerly Muse Biotechnology Inc....
BioCentury | Dec 13, 2017
Company News

Inscripta offers emerging CRISPR enzyme for free

...provide its CRISPR enzyme MAD7 free of charge to researchers for R&D use. Inscripta (formerly Muse Biotechnology Inc....
BioCentury | Mar 3, 2017
Financial News

Muse Biotechnology completes venture financing

...On Feb. 28, genome engineering company Muse Biotechnology Inc. (Boulder, Colo.) raised $23 million in a series B...
...by Venrock. Foresite Capital and Paladin Capital participated, as did existing investors NanoDimension and Spruce/MLS. Muse Biotechnology Inc....
BioCentury | Mar 1, 2017
Financial News

Muse raises $23M in series B

...Genome engineering company Muse Biotechnology Inc. (Boulder, Colo.) said it raised $23 million in an oversubscribed series B...
Items per page:
1 - 4 of 4